The Centers for Disease Control and Prevention (CDC) has updated its RSV vaccine recommendations for older adults. On June 26, the Advisory Committee on Immunization Practices (ACIP) unanimously voted (11 Yes) to recommend that all individuals aged 75 and older receive a single lifetime dose of the RSV vaccine. Additionally, the committee recommended that people aged 60 to 74 with certain underlying health conditions also receive the vaccine. The new guidelines aim to simplify decision-making for patients and clinicians, focusing on those who benefit most from the vaccination. This decision comes as a blow to vaccine manufacturers like GSK, who had hoped for broader recommendations.
CDC revises RSV vaccine recommendations https://t.co/ngaZVpynq9
(US) Advisory Committee on Immunization Practices (ACIP) unanimously voted in favor (11 Yes) to recommend that people ages 60 to 74 who have certain underlying conditions also receive a dose of the vaccine - ACIP Meeting (More at https://t.co/aDRM23LQx1)
(US) Advisory Committee on Immunization Practices (ACIP) unanimously voted in favor (11 Yes) to recommend that all people ages 75 and older receive a single lifetime dose - ACIP Meeting (More at https://t.co/KG1OlpbDYK)
U.S. health officials strengthen endorsement of RSV shots for oldest Americans https://t.co/Eu5xOSMZaH https://t.co/wxHo2z3jU8
Today, CDC updated its RSV vaccine recommendation for people 60 and older. If you have not received a dose, CDC recommends an RSV vaccine if you are: - Age 60–74 with certain chronic health conditions or live in a nursing home - Age 75 & older Read more: https://t.co/EzpTKtSrxE https://t.co/xMi3EmxOeA
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. https://t.co/ikPKh8MXer
A CDC vaccine committee strongly recommended RSV shots for people 75 and older but said adults 60 to 74 should get vaccinated only if at higher risk for severe illness. https://t.co/YcQXZUpd2X
Makers of #RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday. https://t.co/7jAWjwW0W6
“now recommends that all people ages 75 and older receive a single lifetime dose, and that people ages 60 to 74 who have certain underlying conditions also receive a dose of the vaccine.” https://t.co/v1wwKCisq4
CDC panel revises RSV vaccine recommendations for adults The new recommendations are easier to navigate in clinical settings and focus on older age groups who benefit most. https://t.co/tBqhXO2P8G https://t.co/BQp4Ooy9zb
“In the second vote, the committee recommended that people aged 60 to 74 who have health conditions that put them at high risk of severe illness from RSV should also get the vaccine.” https://t.co/OS9rXSeC1a
CDC advisors expand RSV vaccine recommendations, namely for adults 75 and older https://t.co/OOfPlD8Y9E
Pretty interesting discussion today at #ACIP on efforts by makers of #RSV vaccines for adults to expand usage. ACIP recommended everyone 75 & older get one, but deferred making a recommendation on use in people in their 50s, a blow to #GSK. https://t.co/Hcvd0vawPD
CDC advisors expanded their guidance for RSV vaccinations, though not to the degree that manufacturers had hoped. https://t.co/rUCPLI91Q1
"The vaccine will be offered to those aged 18 or over who are at increased risk of contracting avian influenza due to their work or other circumstances” https://t.co/FpW3ALpkiv